Atlas Trials

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Clinical trial NCT04464980 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04464980
Sponsor
NYU Langone Health
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Opioid Use Disorder (OUD)
Start date
2021-06-08
Primary completion
2026-12-31
Enrollment
1516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.